Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals.

  title={Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals.},
  author={Barry R. Holtz and Brian R Berquist and Lindsay D Bennett and Vally J M Kommineni and Ranjith K Munigunti and E. Lucile White and Don C Wilkerson and Kah-Yat I Wong and Lan Ly and Sylvain Marcel},
  journal={Plant biotechnology journal},
  volume={13 8},
Rapid, large-scale manufacture of medical countermeasures can be uniquely met by the plant-made-pharmaceutical platform technology. As a participant in the Defense Advanced Research Projects Agency (DARPA) Blue Angel project, the Caliber Biotherapeutics facility was designed, constructed, commissioned and released a therapeutic target (H1N1 influenza subunit vaccine) in <18 months from groundbreaking. As of 2015, this facility was one of the world's largest plant-based manufacturing facilities… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 24 extracted citations


Publications referenced by this paper.
Showing 1-10 of 31 references

Preclinical and clinical development of plant - made virus - like particle vaccine against avian H 5 N 1 influenza

  • N. Landry, S. Pillet, D. Favre, J. F. Poulin, S. Trepanier, B. Yassine-Diab
  • PLoS ONE
  • 2014
1 Excerpt

The call for agile, flexible facilities: how podular facilities

  • M. W. Jornitz
  • 2014
2 Excerpts

Similar Papers

Loading similar papers…